Cardiology

HCPCS 2013 Code Changes

Cardiology

New
Code	Description
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed;ßsingle major coronary artery or branch
C9601	Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed;ß each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
C9602	Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed;ßsingle major coronary artery or branch
C9603	Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed;ßeach additional branch of a major coronary artery (list separately in addition to code for primary procedure)
C9604	Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed;ßsingle vessel
C9605	Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed;ß each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)
C9606	Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel
C9607	Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty;ßsingle vessel
C9608	Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty;ß each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)
G8919	Most recent systolic blood pressure < 140 mmhg
G8920	Most recent systolic blood pressure >= 140 mmhg
G8921	Most recent diastolic blood pressure < 90 mmhg
G8922	Most recent diastolic blood pressure >= 90 mmhg
G8923	Left ventricular ejection fraction (lvef) < 40% or documentation of moderately or severely depressed left ventricular systolic function
G8934	Left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function
G8935	Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
G8936	Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
G8937	Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given
G8938	Bmi is calculated, but patient not eligible for follow-up plan
G8943	Ldl-c result not present or not within 12 months prior
G8945	Aneurysm minor diameter <= 6 cm for men
G8950	Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up documented
G8951	Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, patient not eligible/not appropriate
G8952	Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
G8956	Patient receiving maintenance hemodialysis in an outpatient dialysis facility
G8957	Patient not receiving maintenance hemodialysis in an outpatient dialysis facility
G8961	Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery
G8962	Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery
G8963	Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years
G8964	Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.G. , symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)
G8965	Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment
G8966	Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment
G8968	Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved not prescribed (e. G. , allergy, risk of bleeding, transient or reversible causes of atrial fibrillation, other medical reasons including, but not limited to pregnancy, mitral stenosis, prosthetic heart valve or patient is in the postoperative period)
G8970	No risk factors or one moderate risk factor for thromboembolism
G8972	One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism
L7902	Tension ring, for vacuum erection device, any type, replacement only, each
C2624	Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components
G9435	Aspirin prescribed at discharge
G9436	Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
G9437	Aspirin not prescribed at discharge
G9438	P2y inhibitor prescribed at discharge
G9439	P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
G9440	P2y inhibitor not prescribed at discharge
G9441	Statin prescribed at discharge
G9442	Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)
G9443	Statin not prescribed at discharge
J7201	Injection, factor ix, fc fusion protein (recombinant), per iu
C2623	Catheter, transluminal angioplasty, drug-coated, non-laser
C9460	Injection, cangrelor, 1 mg
G9507	Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (HIV protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)
G9508	Documentation that the patient is not on a statin medication
G9598	Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted CT or minor diameter on axial formatted CT
G9599	Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted CT or minor diameter on axial formatted CT
G9600	Symptomatic AAAs that required urgent/emergent (non-elective) repair
G9609	Documentation of an order for anti-platelet agents or P2Y12 antagonists
G9610	Documentation of medical reason(s) for not ordering anti-platelet agents or P2Y12 antagonists (e.g., patients with known intolerance to anti-platelet agents such as aspirin or aspirin-like agents, or P2Y12 antagonists, or those on or other intravenous anti-coagulants; patients with active bleeding or undergoing urgent or emergent operations or endarterectomy combined with cardiac surgery, other medical reason(s))
G9611	Order for anti-platelet agents or P2Y12 antagonists was not documented, reason not otherwise specified
G9641	Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure
G9662	Previously diagnosed or have an active diagnosis of clinical ASCVD
G9663	Any fasting or direct LDL-C laboratory test result = 190 mg/dl
G9664	Patients who are currently statin therapy users or received an order (prescription) for statin therapy
G9665	Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy
G9666	The highest fasting or direct LDL-C laboratory test result of 70?189 mg/dl in the measurement period or two years prior to the beginning of the measurement period
G9667	Documentation of medical reason (s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (ESRD), and patients with diabetes who have a fasting or direct LDL-C laboratory test result < 70 mg/dl and are not taking statin therapy)
G9668	Documentation of medical reason (s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (ESRD), and patients with diabetes who have a fasting or direct LDL-C laboratory test result < 70 mg/dl and are not taking statin therapy)
G9673	I intend to report the cardiovascular prevention measures group
G9674	Patients with clinical ASCVD diagnosis
G9677	All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient
P9072	Platelets, pheresis, pathogen reduced, each unit
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml
C9140	Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
C9482	Injection, sotalol hydrochloride, 1 mg
G9680	This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary
G9687	Hospice services provided to patient any time during the measurement period
G9688	Patients using hospice services any time during the measurement period
G9689	Patient admitted for performance of elective carotid intervention
G9690	Patient receiving hospice services any time during the measurement period
G9691	Patient had hospice services any time during the measurement period
G9692	Hospice services received by patient any time during the measurement period
G9693	Patient use of hospice services any time during the measurement period
G9694	Hospice services utilized by patient any time during the measurement period
G9700	Patients who use hospice services any time during the measurement period
G9702	Patients who use hospice services any time during the measurement period
G9707	Patient received hospice services any time during the measurement period
G9709	Hospice services used by patient any time during the measurement period
G9710	Patient was provided hospice services any time during the measurement period
G9713	Patients who use hospice services any time during the measurement period
G9714	Patient is using hospice services any time during the measurement period
G9715	Patients who use hospice services any time during the measurement period
G9718	Hospice services for patient provided any time during the measurement period
G9720	Hospice services for patient occurred any time during the measurement period
G9723	Hospice services for patient received any time during the measurement period
G9724	Patients who had documentation of use of anticoagulant medications overlapping the measurement year
G9725	Patients who use hospice services any time during the measurement period
G9740	Hospice services given to patient any time during the measurement period
G9741	Patients who use hospice services any time during the measurement period
G9744	Patient not eligible due to active diagnosis of hypertension
G9745	Documented reason for not screening or recommending a follow-up for high blood pressure
G9746	Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
G9751	Patient died at any time during the 24-month measurement period
G9758	Patient in hospice and in terminal phase
G9760	Patients who use hospice services any time during the measurement period
G9761	Patients who use hospice services any time during the measurement period
G9768	Patients who utilize hospice services any time during the measurement period
G9781	Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, and patients with end stage renal disease (esrd))
G9782	History of or active diagnosis of familial or pure hypercholesterolemia
G9788	Most recent bp is less than or equal to 140/90 mm hg
G9789	Blood pressure recorded during inpatient stays, emergency room visits, urgent care visits, and patient self-reported bp's (home and health fair bp results)
G9790	Most recent bp is greater than 140/90 mm hg, or blood pressure not documented
G9793	Patient is currently on a daily aspirin or other antiplatelet
G9794	Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed or intra-cranial bleed or documentation of active anticoagulant use during the measurement period
G9795	Patient is not currently on a daily aspirin or other antiplatelet
G9796	Patient is currently on a statin therapy
G9797	Patient is not on a statin therapy
G9798	Discharge(s) for ami between july 1 of the year prior measurement year to june 30 of the measurement period
G9800	Patients who are identified as having an intolerance or allergy to beta-blocker therapy
G9801	Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis`
G9802	Patients who use hospice services any time during the measurement period
G9803	Patient prescribed a 180-day course of treatment with beta-blockers post discharge for ami
G9804	Patient was not prescribed a 180-day course of treatment with beta-blockers post discharge for ami
G9805	Patients who use hospice services any time during the measurement period
G9809	Patients who use hospice services any time during the measurement period
G9814	Death occurring during hospitalization
G9819	Patients who use hospice services any time during the measurement period
G9850	Patient had more than one emergency department visit in the last 30 days of life
G9851	Patient had one or less emergency department visits in the last 30 days of life
G9853	Patient admitted to the icu in the last 30 days of life
G9854	Patient was not admitted to the icu in the last 30 days of life
G9857	Patient admitted to hospice
G9858	Patient enrolled in hospice
G9860	Patient spent less than three days in hospice care
G9861	Patient spent greater than or equal to three days in hospice care
J0883	Injection, argatroban, 1 mg (for non-esrd use)
J0884	Injection, argatroban, 1 mg (for esrd on dialysis)
J7175	Injection, factor x, (human), 1 i.u.
J7179	Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
J7202	Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
J7207	Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
J7209	Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
G9929	Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
G9931	Documentation of cha2ds2-vasc risk score of 0 or 1
G9940	Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)
Q0477	Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only

Revised
Code	Descriptor
G8784	Blood pressure reading not documented, documentation the patient is not eligible
G8968	Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g. patients with mitral stenosis or prosthetic heart valves, patients with transient or reversible causes of af (e.g., pneumonia or hyperthyroidism), postoperative patients, patients who are pregnant, allergy, risk of bleeding, other medical reasons)
C9741	Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report
G8476	Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg
G8477	Most recent blood pressure has a systolic measurement of >=140 mmhg and/or a diastolic measurement of >=90 mmhg
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
G8936	Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) or (eg, lack of drug availability, other reasons attributable to the health care system)
G8968	Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved for the prevention of thromboembolism [eg, patients with mitral stenosis or prosthetic heart valves, patients with transient or reversible causes of af (eg, pneumonia, hyperthyroidism, pregnancy, cardiac surgery), allergy, risk of bleeding, other medical reasons]
G8784	Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)
G9277	Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)
G9298	Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of DVT, PE, MI, arrhythmia and stroke)
G8598	Aspirin or another antiplatelet therapy used
G8599	Aspirin or another antiplatelet therapy not used, reason not given
G8968	Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., allergy, risk of bleeding, other medical reasons)
G9609	Documentation of an order for anti-platelet agents
G9610	Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents
G9611	Order for anti-platelet agents was not documented in the patient's record, reason not given
J7201	Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
P9072	Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit
G8967	Warfarin or another fda approved oral anticoagulant is prescribed
G8968	Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulant (e.g., atrial appendage device in place)
G8969	Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient choice of having atrial appendage device placed)
G9263	Documentation of patient discharged alive following endovascular aaa repair
G9794	Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)

Deleted
Code	Descriptor
G0290	Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel
G0291	Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel
G8469	Clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
G8470	Patient with left ventricular ejection fraction (lvef) >=40% or documentation as normal or mildly depressed left ventricular systolic function
G8471	Left ventricular ejection fraction (lvef) was not performed or documented
G8472	Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function, reason not specified
G8524	Patch closure used for patient undergoing conventional cea
G8525	Clinician documented that patient did not receive conventional cea
G8526	Patch closure not used for patient undergoing conventional cea, reason not specified
G8675	Most recent systolic blood pressure >= 140 mm hg
G8676	Most recent diastolic blood pressure >= 90 mm hg
G8677	Most recent systolic blood pressure < 130 mm hg
G8678	Most recent systolic blood pressure 130 to 139 mm hg
G8679	Most recent diastolic blood pressure < 80 mm hg
G8680	Most recent diastolic blood pressure 80 - 89 mm hg
G8695	Left ventricular ejection fraction (lvef) >= 40% or documentation as mildly depressed left ventricular systolic function or normal
G8715	Hemodialysis treatment performed less than three times per week or greater than three times per week
G8727	Patient receiving hemodialysis, peritoneal dialysis or kidney transplantation
G8786	Severity of angina assessed according to level of activity
G8787	Angina assessed as present
G8788	Angina assessed as absent
G8789	Severity of angina not assessed according to level of activity
G8819	Aneurysm minor diameter <= 5. 5 cm
G8820	Aneurysm minor diameter 5. 6-6. 0 cm
G8821	Abdominal aortic aneurysm is not infarenal
G8822	Male patients with aneurysms minor diameter >6 cm
G8823	Female patients with aneurysm minor diameter >6cm
G8824	Female patients with aneurysm minor diameter 5. 6-6. 0 cm
G8828	Aneurysm minor diameter <= 5. 5 cm for men
G8829	Aneurysm minor diameter 5. 6-6. 0 cm for men
G8830	Aneurysm minor diameter >6cm for men
G8831	Aneurysm minor diameter >6cm for women
G8832	Aneurysm minor diameter 5. 6-6. 0 cm for women
G8836	Symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
G8837	Other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke
G8847	Positive airway pressure therapy not prescribed
S9109	Congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month
A7042	Implanted pleural catheter, each
A7043	Vacuum drainage bottle and tubing for use with implanted catheter
G8547	I intend to report the ischemic vascular disease (ivd) measures group
G8552	All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient
G8582	Beta-blocker at discharge
G8583	Beta-blocker contraindicated
G8584	No beta-blocker at discharge
G8585	Anti-lipid treatment at discharge
G8586	Anti-lipid treatment contraindicated
G8587	No anti-lipid treatment at discharge
G8593	Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
G8594	Lipid profile not performed, reason not given
G8595	Most recent ldl-c < 100 mg/dl
G8597	Most recent ldl-c >= 100 mg/dl
G8682	Lvf testing documented as being performed prior to discharge or in the previous 12 months
G8683	Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason
G8685	Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given
G8699	Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge
G8700	Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge
G8701	Rehabilitation services were not ordered, reason not otherwise specified
G8704	12-lead electrocardiogram (ecg) performed
G8705	Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)
G8706	Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)
G8707	12-lead electrocardiogram (ecg) not performed, reason not given
G8738	Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function
G8739	Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
G8740	Left ventricular ejection fraction (lvef) not performed or assessed, reason not given
G8763	All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient
G8764	All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient
G8767	Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
G8768	Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8769	Lipid profile not performed, reason not given
G8886	Most recent blood pressure under control
G8887	Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8888	Most recent blood pressure not under control, results documented and reviewed
G8889	No documentation of blood pressure measurement, reason not given
G8890	Most recent ldl-c under control, results documented and reviewed
G8891	Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8892	Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8893	Most recent ldl-c not under control, results documented and reviewed
G8894	Ldl-c not performed, reason not given
G8895	Oral aspirin or other antithrombotic therapy prescribed
G8896	Documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)
G8897	Oral aspirin or other antithrombotic therapy was not prescribed, reason not given
G8904	I intend to report the hypertension (htn) measures group
G8905	I intend to report the cardiovascular prevention measures group
G8930	Assessment of depression severity at the initial evaluation
G8931	Assessment of depression severity not documented, reason not given
G8932	Suicide risk assessed at the initial evaluation
G8933	Suicide risk not assessed at the initial evaluation, reason not given
G8943	Ldl-c result not present or not within 12 months prior
G8949	Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)
C9457	Injection, sulfur hexafluoride lipid microsphere, per ml
G8951	Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible
G9323	Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (e.g., CT studies performed for radiation treatment planning or image-guided radiation treatment delivery)
A4466	Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each
C9121	Injection, argatroban, per 5 mg
C9137	Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
C9138	Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
C9139	Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
G8489	I intend to report the coronary artery disease (cad) measures group
G8497	All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient
G8498	All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient
G8544	I intend to report the coronary artery bypass graft (cabg) measures group
G8548	I intend to report the heart failure (hf) measures group
G8551	All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient
G8725	Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)
G8726	Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)
G8728	Fasting lipid profile not performed, reason not given
G8784	Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)
G9435	Aspirin prescribed at discharge
G9436	Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
G9437	Aspirin not prescribed at discharge
G9438	P2y inhibitor prescribed at discharge
G9439	P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
G9440	P2y inhibitor not prescribed at discharge
G9441	Statin prescribed at discharge
G9442	Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)
G9443	Statin not prescribed at discharge
G9667	Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)
G9673	I intend to report the Cardiology prevention measures group
G9677	All quality actions for the applicable measures in the Cardiology prevention measures group have been performed for this patient
C9140	Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
G8696	Antithrombotic therapy prescribed at discharge
G8697	Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))
G8698	Antithrombotic therapy was not prescribed at discharge, reason not given
G8971	Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
G8972	One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism